Hangping Yao

InstitutionZhejiang University
AddressHangzhou
Zhejiang
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 2 publications in October 2020 and December 2020 and July 2021 and August 2021
    All Publications
    Bar chart showing 74 publications over 18 distinct years, with a maximum of 11 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chen Y, Yao H, Fu J, Shu Q, Chen Z, Wu N, Ye S, Wang W, Ni Y, Shang S, Li W, Zheng J, Li S, Hong L, Zhang Q, Xu W, Chen J, Fan L, Cang X, Wang J, Lu X, Cao Q. The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study. Int J Infect Dis. 2021 Oct; 111:347-353. PMID: 34454120.
      Citations: 1     Fields:    Translation:Humans
    2. Lou Y, Zhao W, Wei H, Chu M, Chao R, Yao H, Su J, Li Y, Li X, Cao Y, Feng Y, Wang P, Xia Y, Shang Y, Li F, Ge P, Zhang X, Gao W, Song G, Du B, Liang T, Qiu Y, Liu M. Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies. Biotechnol J. 2021 Nov; 16(11):e2100207. PMID: 34379353.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Shi D, Weng T, Wu J, Dai C, Luo R, Chen K, Zhu M, Lu X, Cheng L, Chen Q, Liu F, Wu Z, Wu H, Jin C, Guo M, Chen Z, Wu N, Yao H, Zheng M. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study. Front Immunol. 2021; 12:708184. PMID: 34354712.
      Citations: 1     Fields:    Translation:HumansCells
    4. Jin C, Yu B, Zhang J, Wu H, Zhou X, Yao H, Liu F, Lu X, Cheng L, Jiang M, Wu N. Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis. 2021 Jul 09; 21(1):672. PMID: 34243711.
      Citations:    Fields:    
    5. Chen Y, Yao H, Zhang N, Wu J, Gao S, Guo J, Lu X, Cheng L, Luo R, Liang X, Wong CCL, Zheng M. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage. J Proteome Res. 2021 07 02; 20(7):3463-3474. PMID: 34080435.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    6. Jin C, Yu B, Zhang J, Wu H, Zhou X, Yao H, Liu F, Lu X, Cheng L, Jiang M, Wu N. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis. 2021 Apr 16; 21(1):357. PMID: 33863281.
      Citations: 6     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Yao H, Sun Y, Deng YQ, Wang N, Tan Y, Zhang NN, Li XF, Kong C, Xu YP, Chen Q, Cao TS, Zhao H, Yan X, Cao L, Lv Z, Zhu D, Feng R, Wu N, Zhang W, Hu Y, Chen K, Zhang RR, Lv Q, Sun S, Zhou Y, Yan R, Yang G, Sun X, Liu C, Lu X, Cheng L, Qiu H, Huang XY, Weng T, Shi D, Jiang W, Shao J, Wang L, Zhang J, Jiang T, Lang G, Qin CF, Li L, Wang X. Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection. Cell Res. 2021 01; 31(1):25-36. PMID: 33262452.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    8. Jin X, Xu K, Jiang P, Lian J, Hao S, Yao H, Jia H, Zhang Y, Zheng L, Zheng N, Chen D, Yao J, Hu J, Gao J, Wen L, Shen J, Ren Y, Yu G, Wang X, Lu Y, Yu X, Yu L, Xiang D, Wu N, Lu X, Cheng L, Liu F, Wu H, Jin C, Yang X, Qian P, Qiu Y, Sheng J, Liang T, Li L, Yang Y. Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site. Emerg Microbes Infect. 2020 Dec; 9(1):1474-1488. PMID: 32543348.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    9. Yao H, Lu X, Chen Q, Xu K, Chen Y, Cheng M, Chen K, Cheng L, Weng T, Shi D, Liu F, Wu Z, Xie M, Wu H, Jin C, Zheng M, Wu N, Jiang C, Li L. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 2020 Oct 29; 6(1):76. PMID: 33298872.
      Citations: 16     
    10. Lou Y, Liu L, Yao H, Hu X, Su J, Xu K, Luo R, Yang X, He L, Lu X, Zhao Q, Liang T, Qiu Y. Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial. Eur J Pharm Sci. 2021 Feb 01; 157:105631. PMID: 33115675.
      Citations: 51     Fields:    Translation:Humans
    11. Yao H, Song Y, Chen Y, Wu N, Xu J, Sun C, Zhang J, Weng T, Zhang Z, Wu Z, Cheng L, Shi D, Lu X, Lei J, Crispin M, Shi Y, Li L, Li S. Molecular Architecture of the SARS-CoV-2 Virus. Cell. 2020 10 29; 183(3):730-738.e13. PMID: 32979942.
      Citations: 169     Fields:    Translation:HumansAnimalsCells
    12. Wang X, Yao H, Xu X, Zhang P, Zhang M, Shao J, Xiao Y, Wang H. Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2). Clin Chem. 2020 07 01; 66(7):977-979. PMID: 32282874.
      Citations: 46     Fields:    Translation:HumansCellsPHPublic Health
    13. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, Xie G, Lin S, Wang R, Yang X, Chen W, Wang Q, Zhang D, Liu Y, Gong R, Ma Z, Lu S, Xiao Y, Gu Y, Zhang J, Yao H, Xu K, Lu X, Wei G, Zhou J, Fang Q, Cai H, Qiu Y, Sheng J, Chen Y, Liang T. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443. PMID: 32317267.
      Citations: 486     Fields:    Translation:HumansCellsPHPublic Health
    14. Gao H, Yao H, Yang S, Li L. From SARS to MERS: evidence and speculation. Front Med. 2016 Dec; 10(4):377-382. PMID: 27726088.
      Citations: 25     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Yao's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (242)
    Explore
    _
    Co-Authors (209)
    Explore
    _
    Similar People (60)
    Explore
    _